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Background: High cholesterol is identified as a major risk factor for chronic non-communicable diseases,
especially cardiovascular and cerebrovascular diseases. Monitoring trends of cholesterol levels and comparing
trends across population groups are important to assess population distribution and risks related to
cholesterol change over time. Cholesterol surveillance data are lacking, even in high-income countries.
Objectives: To describe the trends in cholesterol and triglyceride levels in different population groups and to
estimate the risk of developing hypercholesterolemia and hypertriglyceridemia in Va ¨sterbotten County,
Sweden during 19902010.
Designs and Methods: Since 1990, 133,082 individuals living in Va ¨sterbotten County, Northern Sweden,
invited on their 30th, 40th, 50th and 60th birthdays, participated in the Va ¨sterbotten Intervention Program.
Ten years after baseline data collection, 34,868 individuals were surveyed for a second time. In addition to a
self-administered health questionnaire (that included information on socioeconomic status, demographics,
self-reported health and lifestyle behaviours), blood cholesterol and triglyceride were examined.
Results: The level and prevalence of hypercholesterolemia decreased significantly from 1990 to 2007, but the
trends began to increase during 20082010 in men, women, and in all educational groups. Men had
significantly higher serum triglyceride levels than women and their cholesterol levels were similar to those of
the women. This study shows that those with basic education and who live in rural inlands had consistently
higher triglyceride level than those who live in the city and have higher educational attainments. People with
basic education are also at higher riskof developing hypercholesterolemia and hypertriglyceridemia at 10-year
follow-up; the risk is much higher among the older cohorts, particularly women. During 19902010, the
proportion of participants who reported treatment with lipid-lowering agents increased from 1.1% to 9.6%
among men and 0.5% to 5.3% among women. About 60% of those treated achieved treatment goals for
cholesterol or triglycerides.
Conclusions: The increasing trend in cholesterol level in the Va ¨sterbotten population during 20082010 needs
to be closely monitored. Addressing the unequal distribution of cholesterol, as well as other risk factors such
as obesity, physical inactivity, high blood glucose, among those with basic education, and particularly among
populations in rural areas are important to prevent higher burdens of chronic non-communicable diseases in
this population.
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I
n 2004, approximately 60% of global deaths were
attributable to chronic non-communicable diseases,
primarilycardiovasculardiseases(CVD),cancers,and
respiratory diseases. Cardiovascular diseases, including
ischaemic heart disease and cerebrovascular disease,
accounted for total mortality in 32% of men and 27%
of women. The Global Burden of Disease project esti-
mated that 22% of the 21.3 million global CVD deaths
occurred in high-income countries, mainly in American
and European countries. Of the 1.5 million CVD deaths in
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ischaemic heart disease and 25% to cerebrovascular
disease (1).
Several large epidemiological studies show a reduction
in CVD mortality over the last few decades (24). Results
from the longitudinal Framingham Heart Study show a
59% decrease in coronary heart disease (CHD) death
rates from 1950 to 1999 (2). The WHO MONICA study
was conducted in 38 populations in 21 countries and
reports annual percentage decreases in coronary event
rates of 2.3% in men and 1.4% in women (5), but these
rates differ significantly between and within the different
study populations (3). In Australia, CHD mortality
decreased by 74% in men and 81% in women over the
period of 19682000, and the decrease was primarily
attributable to reductions in population risk factors for
primary and secondary prevention (4). In Sweden, the
death rate from cardiovascular diseases among women
aged 1574 years decreased significantly from 128/
100,000 in 1987 to 55/100,000 in 2010. The corresponding
rates for men were 352/100,000 in 1987 and 126/100,000
in 2010. Yet, among Swedish adults, CVD was the
leading cause of death for 41% of all deaths among
women and 39% among men in 2010 (6).
Reduction of population serum cholesterol levels
through primary and secondary prevention strategies,
such as reduction of dietary fat, increasing use of lipid-
lowering agents, better management of hypertension, and
increasing use of antiplatelet and thrombolytic agents are
believed to account for the reduction in CHD mortality
(2, 4). In Australia, a decrease in population serum
cholesterol levels, mainly due to changes in dietary
saturated fat consumption, accounted for a reduction in
CHD mortality of 22% among men and 20% among
women over the period of 19682000 (4). The WHO
MONICA study estimates 40% of men’s and 15% of
women’s variability in coronary event rate trends are
attributable to changes in the major CVD risk factors (ie,
smoking, blood pressure, blood cholesterol, and body
mass index) (5). Hypercholesterolemia (defined as blood
cholesterol over 6.5 mmol/L) with raised low-density
lipoprotein cholesterol (LDL-C), which is the main form
of dyslipidaemia, are present in 2080% of adults of
European descent (7). The global population average of
total cholesterol has changed by less than 0.1 mmol/L per
decade between 1980 and 2008. A larger decrease was
observed in Australasia, North America, and Western
Europe (8). Decreased population serum cholesterol has
also been reported in many countries that participate in
the WHO MONICA project (9). In the Northern Sweden
MONICA, the prevalence of hypercholesterolemia (cho-
lesterol ] 7 mmol/L) in men aged 2564 years decreased
from 28.6% in 1986 to 10.5% in 2009; the corresponding
decrease was from 26.2% to 8.4% in women. Mean
cholesterol among men aged 2564 years old decreased
from 6.4 mmol/L in 1986 to 5.6 mmol/L in 2009; the
corresponding numbers were 6.3 mmol/L and 5.4 mmol/L
in women (10).
The Va ¨sterbotten Intervention Program (VIP) was
developed in the mid 1980s in response to high myocar-
dial infarction mortality rates in Va ¨sterbotten County in
early 1980. In 1985, the mortality rate of myocardial
infarction in Va ¨sterbotten County was 546/100,000
population/year in men and 324/100,000/year in women.
These compare to rates of 136/100,000 population/year in
men and 91/100,000 population/year in women living in
Gotland County in southern Sweden (11). VIP started
initially with a small-scale intervention program in
Norsjo ¨ Municipality in Va ¨sterbotten County in 1985.
This was expanded to the whole county during 19901992
(12). The VIP model includes population-based and
individual prevention strategies. In the latter strategy,
middle-aged individuals are invited to participate in
health screening and individual counselling in primary
health care centre. In addition to self-administered
questionnaires, participants are offered fasting blood
glucose and blood cholesterol examinations (13). The
objectives of this study are to describe the trends in
cholesterol and triglyceride levels in Va ¨sterbotten County,
Sweden and to estimate the risk of developing hyperch-
olesterolemia and hypertriglyceridemia in this population
during 19902010.
Methods
Study participants
Since 1990, all individuals aged 30, 40, 50, and 60 years
who live in Va ¨sterbotten County, Sweden are invited
to participate in a health examination at their local
health care centres. The response rate to this invitation
has increased from 59% in 1995 to 69% in 2010. By
2010, 133,082 health examinations were conducted and
recorded in a cross-sectional database. In the cross-
sectional analysis, we excluded individuals aged 30 (n
9,136) as only few health centres continued to invite them
after 1995. The panel data (n34,868 individuals)
consists of individuals who participated in follow-up
examination ten years after their initial examination.
We included individuals age 30 who participated during
19901995 in the panel data analysis. This allows
individuals aged 30, 40 and 50 years to participate in
the survey a second time when they turn 40, 50 or
60 years old. The panel data also consists of 1,042
individuals who had participated three times in VIP (in
1990, 2000, and 2010). We excluded the third observation
from the panel analysis. Details about the study popula-
tion have been reported elsewhere (13).
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Each participant completed a self-administered health
questionnaire that included socioeconomic and demo-
graphic status, self-reported health, and lifestyle be-
haviours. Subjects were categorized into three groups
based on their highest educational level: basic education
(ie, those who completed only elementary and compre-
hensive compulsory school), medium education (ie, those
who graduated from residential college for adult educa-
tion or high school); and high education (ie, those who
graduated from college). Based on their area of residence,
participants were categorized into those who lived in (1)
Umea ˚ city, (2) Skelleftea ˚ town, (3) Lycksele town, (4)
rural coastlands (communities of Nordmaling, Roberts-
fors, Va ¨nnas, and Vindeln), and (5) rural inlands (com-
munities of A ˚ sele, Bjurholm, Dorotea, Mala ˚, Norsjo ¨,
Sorsele, Storuman, and Vilhelmina).
Staff at each health care centre performed blood
pressure measurements and blood sampling. A venous
blood sample was obtained after an overnight fast. Serum
total cholesterol and triglycerides were analysed in each
health care centre using Reflotron bench-top analysers
(Boehringer Mannheim GmbH, Mannheim, Germany)
(14). On Sept. 1, 2009, the VIP blood sampling protocol
was updated and all blood samples were sent to the
Department of Clinical Chemistry in the nearest hospital
in Umea ˚, Lycksele and Skelleftea ˚ for analysis. To ensure
comparability of results analysed through both methods,
we conducted the calibration protocol on total choles-
terol (n1,197) and triglycerides (n838) for VIP
participants whose blood samples were analysed using
both Reflotron and laboratory chemistry. Results from
blood samples sent to the Departments of Clinical
Chemistry were adjusted to Reflotron-comparable values
using the following formula:
Reflotron-based serum triglyceride  0.177  (0.932 
serum triglyceride by laboratory chemistry)
Reflotron-based serum cholesterol  0.170  (0.939 
serum cholesterol by laboratory chemistry)
Participants with blood cholesterol levels ]6.5 mmol/L
and/or those who took lipid-lowering medication within
14 days were categorized as the hypercholesterolemia
group. Serum triglyceride of ]1.7 mmol/L was used to
define hypertriglyceridemia.
Statistical analyses
We grouped observations from the last three years period
separately, in order to ensure comparability of the six
years interval (19901995, 19962001, and 20022007)
used in other papers in the VIP series published earlier
(1518). Mean levels of total cholesterol and triglycerides
were adjusted for age, and are presented graphically by
sex, educational level and survey year. These time-trend
data were also adjusted for age, educational level and sex
when the data were presented graphically by geographical
area. Prevalences of hypercholesterolemia and hypertri-
glyceridemia were adjusted for age and presented with
99% confidence intervals (CI). The 10-year risks of
developing hypercholesterolemia or hypertriglyceridemia
were calculated for each age cohort using the predicted
probability following logistic regression analysis for each
sex, controlling for age and educational level. Risk was
calculated separately for cohorts recruited during 1990
1995 and 19962000. We compared the proportion of
hypercholesterolemia and hypertriglyceridemia in the
panel at baseline and 10-year follow-up. Finally, we
calculated the proportion of men and women among
those who reported taking lipid-lowering medication
during the last 14 days with cholesterol]5 mmol/L and
triglycerides]1.7 mmol/L, the recommended levels.
Statistical analyses were conducted with Stata Version
11.2 (19). Time-trends were graphed with two-year
moving averages using the graph function in Microsoft
Excel. A p-value of 0.01 was used to signify statistical
significance so as to take into consideration the large
sample size.
Results
Of the 123,946 VIP participants aged 40, 50 and 60 years
during 19902010, 121,972 (98.4%) individuals had
complete information on cholesterol and educational
levels and were included in the analyses. In total, 48.3%
of the participants were men, 24.5% had basic education,
and 48.4% had medium education. The proportion of
participants aged 40, 50 and 60 years were 33.4%, 35.2%,
and 31.4%, respectively. The panel analyses included
16,305 men and 18,563 women who had 10 year
follow-up data.
Trends of population cholesterol and triglycerides in
Va ¨sterbotten County
The age-adjusted cholesterol level had decreased from
5.90 mmol/L (99% CI 5.875.92) in 19901995 to 5.25
(5.235.27) in 20022007, and later increased to 5.31
(5.285.34) in 20082010 among men. The corresponding
numbers were 5.82 (5.805.84), 5.24 (5.225.26), and 5.28
(5.255.31) in women (data not shown). These changes in
cholesterol level had also been reflected in the reverting
trend of hypercholesterolemia, which showed statistically
significant increases from 14.7% to 18.3% in men and
9.9% to 12.5% in women between 20022007 and 2008
2010 (Table 1). Similar trends had also been observed in
triglyceride level in men and women. It decreased from
1.65 mmol/L (1.621.67) to 1.55 (1.531.56) and later
increased to 1.59 (1.571.62) in men. In women, it seemed
that triglyceride level continued to decrease in the last
3 years period also. The levels of triglyceride in women
changed from 1.38 (1.371.40) in 19901995 to 1.27
Trends of cholesterol in Va ¨sterbotten County, Sweden
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1.25 (1.241.27) in 20082010 (data not shown). These
patterns were reflected in the prevalence of hypertrigly-
ceridemia as shown in Table 1.
Trends of population cholesterol and triglycerides in
educational groups
In general, men had significantly higher serum triglycer-
ide levels than women. During 19902010, both men and
women with basic education had consistently higher
levels of age-adjusted cholesterol and triglycerides com-
pared to those with medium or high educational levels.
The differences in cholesterol and triglyceride levels
across educational groups were more prominent among
women than men. Differences in blood cholesterol levels
among the educational groups were observed during the
first 6 years (19901995) and became less prominent
during 20022010, particularly among men. In both sexes
and all educational groups, cholesterol levels decreased
between 19902001, remained stable during 20022007,
and showed an increasing trend from 20082010. In
contrast, the triglyceride levels fluctuated during 1990
2010, and 2010 levels were similar to those in 1990
(Fig. 1).
The age-adjusted prevalence of hypercholesterolemia
decreased significantly in men and women, as well as all
educational groups from 19901995 to 20022007. Dur-
ing 20082010, prevalences increased among men and
women and all educational groups. Statistically signifi-
cant increases were observed among men and women
with medium education, and the prevalence of hyperch-
olesterolemia in men increased from 13.8% in 20022007
to 17.8% in 20082010. Prevalences increased from 9.1%
to 12.8% in women during corresponding periods. The
age-adjusted prevalence of hypertriglyceridemia showed a
decreasing trend from 1990 to 2001. After 2001, pre-
valences increased in men, women, and all educational
groups. The prevalences of hypertriglyceridemia in men
and women during 20082010 were similar to those
during 19901995, except for women with basic educa-
tion who had a significantly lower prevalence of 22.9%
in 20082010, compared to a prevalence of 29.1%
in 19901995 (Table 1).
Population trends in cholesterol and triglycerides in
different geographical areas
In the earlier period, participants who lived in the town of
Lycksele, rural coastlands, and rural inland areas showed
a higher cholesterol level compared to those who lived in
the city of Umea ˚ or town of Skelleftea ˚. The cholesterol
level decreased over time in all geographical areas until
2003, except for those who lived in Lycksele where the
decreasing trend rebounded earlier, in 2000. The choles-
terol level among inhabitants of Lycksele increased from
5.29 mmol/L in 2001 to 5.66 mmol/L in 2010 (Fig. 2). T a b l e
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inhabitants of Lycksele decreased from 44% in 1993 to
12.4% in 2000; thereafter it increased steadily to the level
of 24% in 2010. During 20022007, the prevalence of
hypercholesterolemia in the other four regions was more
than 5% lower than in Lycksele. Since 2007, it has
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Fig. 1. Levels of (a) serum cholesterol (mmol/L) and (b) serum triglycerides (mmol/L) among adults in the Va ¨sterbotten
Intervention Programme, 19902010. The levels are adjusted for age.
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(page number not for citation purpose)increased in these four regions and the prevalence in the
rural inlands reached the level of that in Lycksele in 2010
(data not shown). For those who live in the rural inlands,
cholesterol levels reached the nadir in 2002 and increased
to 5.5 mmol/L in 2010. Although the cholesterol levels
were stable during 20022007 in the other three areas,
there was an increasing trend during 20082010. In 2010,
Umea ˚ inhabitants had the lowest cholesterol levels (5.34
mmol/L) and prevalence of hypercholesterolemia (16%)
as compared to VIP participants in other geographical
areas. The serum triglyceride trends were more consistent:
individuals who lived in the city of Umea ˚ or town
of Skelleftea ˚ had lower triglyceride levels during the
whole observation period than individuals who lived
in other areas. Inhabitants in the rural inlands also
had higher triglyceride level throughout the observation
period (Fig. 2).
Ten-year risk of developing hypercholesterolemia or
hypertriglyceridemia
The panel data show that the ten-year risk of developing
hypercholesterolemia was significantly higher among
40- and 50-year old men with medium or high education
who were recruited during 19962000, compared to those
recruited earlier. The same was true for 50-year old
women with medium or high education. Men and
women in all age cohorts who had basic education were
at significantly higher risk of developing hypercho-
lesterolemia than those with high education. This was
true only among those who participated in the early
period (19901995). The differences in risk across educa-
tional groups diminished in the later period. Younger
women had significantly lower risk for hypercholester-
olemia as compared to younger men. The risk differences
between younger (30-year old) and older women (40- and
50-year olds) were larger than the different age-cohorts
among men. These observations were similar across all
educational groups. The 10-year risk of developing
hypertriglyceridemia was higher among the older women
(40- and 50-year olds) than their younger counterparts.
Among 50-year old men, the risk of developing hyper-
triglyceridemia was lower than that of the 30-year old
men. There was no difference in risk between men with
basic and high education or between women with basic
and medium education among those recruited in 1990
1995 (Fig. 3).
The 40- and 50-year female cohorts showed statistically
significant higher proportions of hypercholesterolemia
and hypertriglyceridemia across all educational groups at
10-year follow-up compared to the proportions in the
baseline survey. In contrast, 30-year women with medium
or high education and 50-year men with basic or medium
education had a significantly lower proportion of hy-
percholesterolemia at 10-year follow-up. Though not
statistically significant, the proportion of hypercholester-
olemia was lower among 30- and 40-year men at
10-year follow-up. This was observed in most educational
groups. In men, no statistically significant difference was
observed in the proportion of hypertriglyceridemia
between baseline and 10-year follow-up except for a
higher proportion of hypertriglyceridemia among 30- and
40-year men with medium education at 10-year follow-up
(Table 2).
Trends in self-reported treatment with lipid-lowering
agents
During 19902010, the proportion of VIP participants
who reported treatment with lipid-lowering agents
increased from 1.1% to 9.6% among men and from
0.5% to 5.3% among women. In both sexes, the increase
was consistently higher among respondents with basic
education than those with medium or high education,
and the gaps became more prominent during the last
10 years (Fig. 4). Although the proportion on treatment
increased over time, only half of those in each sex and
educational group who were categorized as hypercholes-
terolemia reported treatment. In a more detailed analysis
limited to those individuals with high cholesterol level
(] 6.5 mmol/L), we observed that 50% of men with basic
education reported taking lipid-lowering treatment
within the two weeks preceding the survey. This propor-
tion was higher than the 35% of men with medium
education and 43% of men with high education. The
corresponding numbers were 33%, 26%, and 23% among
women with basic, medium and high education, respec-
tively. The treated proportion was lower when the
analysed data included those with high serum triglycer-
ides. Less than 15% of those with hypertriglyceridemia
reported treatment during the two weeks preceding the
survey, and the proportion was higher among men and
women with basic education (data not shown).
Control of population blood lipids with treatment
We analysed the proportion of respondents with serum
cholesterol and triglyceride levels above the treatment
goals of cholesterol B5.0 mmol/L and triglycerides
B1.7 mmol/L who reported lipid-lowering treatment in
the prior two weeks. Despite the large number of study
participants, only 311 men and 173 women reported
treatment in 2010. The proportion of ‘uncontrolled’
cholesterol dropped significantly from approximately
90% in 1990 to 3040% in 2010. This was higher among
women throughout the observation period. The pro-
portion of ‘uncontrolled’ triglycerides decreased from
approximately 70% in 1990 to 40% in 2010. Although the
proportion was higher in women during the earlier
period, the level have been higher among men since
1998 (Fig. 5).
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Unsustainable improvement  reversal of population
cholesterol levels
Blood cholesterol levels among the northern Sweden
population decreased steadily after 1990, reached a
plateau during 20002007, and thereafter have increased
among men and women as well as all educational groups.
The observation period was short during 20082010, but
the increasing trend in population cholesterol levels
seen in this study area should be addressed seriously.
This is especially important because the 2010 levels
resemble patterns seen ten years ago. The northern
Sweden MONICA study also reported a decline in
cholesterol levels among their 2564 years old population
between 1986 and 2009. Women aged 2564 years old
consistently had cholesterol levels 15% higher than men
during the survey years of 1986, 1990, 1994, 1999, 2004,
and 2009 (10). Unlike the MONICA study, our study
found that men had cholesterol levels 12% higher than
women during 19902001. After that time, the levels have
had a difference of less than 1%.
Our hypothesis was that the increase in population
cholesterol levels during 20082010 was not uniform
across different geographical regions in the study area.
This was not proven. Instead, increases were observed
consistently in all geographical areas, from the rural
inlands to large cities. The population in the rural inlands
has consistently shown higher serum triglycerides than
those who live in other areas. This might be explained by
the higher prevalence of overweight, obesity, and physical
inactivity observed in rural inlands (15, 18). High serum
triglycerides are associated with obesity, sedentary life-
style and alcohol consumption (20).
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Fig. 3. Ten-year risk of developing (a) hypercholesterolemia and (b) hypertriglyceridemia among participants in the
Va ¨sterbotten Intervention Programme. Risk is presented as a function of age at the start of the 10-year period and education,
adjusted for baseline levels of cholesterol and triglycerides.
Note: The 30-year cohort during 19962000 is not presented as only few individuals were invited to the study since 1995.
The 10-year risk was estimated using the predicted probability after logistic regression analysis for each sex, controlling
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(page number not for citation purpose)This study also found a steady decrease in the
prevalence of hypercholesterolemia until 20022007
followed by an increase during 20082010. We observed
statistical significant increases in the prevalence between
20022007 and 20082010 only among respondents with
medium education. Even though the 99% CI between
Table 2. Proportions of men and women with hypercholesterolemia and hypertriglyceridemia during the baseline and 10-year
follow-up periods in the Va ¨sterbotten Intervention Programme
Men Women
Groups* Baseline 10-year follow-up Baseline 10-year follow-up
Hypercholesterolemia (%)
30-year-old panel
Basic education 13.2 (9.518.2) 10.9 (7.515.7) 4.4 (2.47.9) 4.1 (2.17.6)
Medium education 8.8 (7.610.1) 9.4 (8.210.8) 5.1 (4.26.2) 3.1 (2.44.0)
High education 8.4 (6.011.6) 7.8 (5.511.1) 4.6 (3.36.3) 1.5 (0.82.6)
40-year-old panel
Basic education 22.4 (20.025.0) 21.8 (19.424.4) 10.3 (8.612.3) 13.6 (11.615.8)
Medium education 19.1 (17.920.3) 17.1 (16.018.3) 9.3 (8.410.2) 12.1 (11.213.2)
High education 15.6 (13.817.5) 14.5 (12.816.4) 6.5 (5.77.6) 9.4 (8.410.6)
50-year-old panel
Basic education 31.4 (29.533.3) 26.6 (24.828.4) 26.4 (24.728.2) 30.3 (28.532.1)
Medium education 28.3 (26.729.9) 25.0 (23.526.5) 20.8 (19.522.2) 28.1 (26.629.6)
High education 23.6 (21.426.0) 21.8 (19.724.1) 18.0 (16.419.7) 24.6 (22.826.5)
Hypertriglyceridemia (%)
30-year-old panel
Basic education 23.8 (18.030.8) 28.6 (23.135.0) 16.6 (12.022.4) 19.7 (15.025.5)
Medium education 23.4 (21.225.7) 29.8 (27.831.8) 11.2 (9.712.8) 10.5 (9.111.9)
High education 16.9 (11.923.3) 22.3 (18.326.9) 7.7 (5.810.1) 6.4 (4.88.4)
40-year-old panel
Basic education 34.2 (31.037.5) 34.6 (31.737.6) 13.8 (11.716.2) 21.5 (19.124.1)
Medium education 28.1 (26.629.7) 32.7 (31.334.2) 11.6 (10.612.7) 16.8 (15.718.0)
High education 24.1 (21.427.1) 26.1 (23.928.4) 7.9 (6.89.1) 12.0 (10.813.3)
50-year-old panel
Basic education 34.2 (32.036.4) 30.5 (28.732.4) 20.6 (19.022.4) 26.9 (25.228.7)
Medium education 32.5 (30.734.4) 29.5 (28.031.1) 17.4 (16.118.9) 25.2 (23.826.7)
High education 26.4 (23.729.4) 27.3 (25.029.7) 12.6 (11.114.3) 17.8 (16.219.5)
*Age of panel is age at baseline survey
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Fig. 4. Proportions of individuals who reported taking lipid-lowering treatment in the Va ¨sterbotten Intervention Programme,
19902010. Proportions are adjusted for age.
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with basic and high education, the overlap are very
marginal (except for women with basic education), which
might disappear if we use 95% CI instead. Therefore
being conservative, we believe that these results from this
large population survey, which show an increase in the
prevalence of hypercholesterolemia during the last three
years, are robust.
Gaps were found in the prevalence of hypercholester-
olemia among men and women. Individuals with basic
education have a significantly higher prevalence of
hypercholesterolemia than those with medium or high
education. The higher prevalence of overweight and
obesity (15), and physical inactivity (18) among indivi-
duals with basic education in this study area might
explain the unfavourable lipid patterns in this population
subgroup. These two factors are independent risk factor
for hypertriglyceridemia (20). In women, endogenous
hormones and exogenous reproductive hormones influ-
ence triglyceride levels. Higher triglyceride levels are
observed among menopausal women. It is unclear
whether the change in triglycerides is attributable to the
menopausal hormonal transition or is an effect of ageing
or lifestyle changes among postmenopausal women.
Risk of developing dyslipidaemia
The 10-year risks of developing hypercholesterolemia and
hypertriglyceridemia were higher among men recruited in
19962000 than those recruited in the earlier period
19901995. These patterns were less prominent in women.
Because the 10-year risk of hypercholesterolemia for
those recruited in 19962000 was measured during
follow-up in 20062010, one might hypothesize that the
higher risk in the later cohort is associated with the
changes in dietary patterns during this period. The low-
carbohydrate high-fat diet, a more extreme form of
carbohydrate-restricted diet, was introduced into Sweden
in 2005. Since that time, it has received much interest
from the general public and the debates have been
intensive at the national level. The appropriateness of
the diet for diabetic patients or for weight loss has been
questioned (21). A systematic review conducted by the
Swedish Council on Health Technology Assessment ex-
pert group concluded that scientific evidence for the
effects of low-carbohydrate high-fat (LCHF) diets, at
least in diabetic patients, is insufficient due to a lack of
studies with adequate study quality. The experts stated
that the more extreme form of a carbohydrate-restricted
diet must be used with caution, and individuals eating a
low-carbohydrate high-fat diet ought to observe whether
the new diet incurs negative consequences on risk factors
in general and LDL-cholesterol in particular. At the same
time, the expert group suggested that both traditional
low-fat diets and moderate carbohydrate-restricted diets
with an increase in unsaturated fatty acids, could function
well for diabetic patients (22). Dietary saturated fat is pro-
ven to increase LDL-cholesterol, yet combination diets
rich in polyunsaturated fat might modify this effect (23).
Our study shows that the women in the 50-year old
cohort had a significantly higher risk of developing
hypercholesterolemia in the next 10 years than the
30-year old cohort. Although complex biological
mechanisms between menopause and cholesterol are yet
to be fully elucidated, different studies report a higher
level of total cholesterol among postmenopausal women
compared to premenopausal women (2426). In the
cross-sectional analysis of the Third French MONICA
study, Agrinier et al. (2009) report higher age-adjusted
total cholesterol and LDL-cholesterol in postmenopausal
women. The association remained after adjustment for
lipid-lowering therapy, diabetes, hormone replacement
therapy, and blood pressure lowering therapy (26). Hak
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(page number not for citation purpose)et al. (2004) assessed the contribution of genetic variation
to cholesterol levels among postmenopausal women,
and concluded that APOE genotype modifies the extent
of cholesterol increase after menopause. Women with
APOE3E3 have higher risk of hypercholesterolemia than
women with APOE2E3 (27).
Treatment for dyslipidaemia: coverage and control
The increased use of lipid-lowering agents, despite a
decreasing prevalence of hypercholesterolemia and hyper-
triglyceridemia, may reflect better coverage of the treat-
ment among those in need. The proportion receiving
treatment is about half of the prevalent hypercho-
lesterolemia. However, the need of pharmacological
treatment depends largely on whether the individuals
also exhibit other cardiovascular risk markers and on
the effectiveness of non-pharmacological interventions.
The National Cholesterol Education Program Expert
Panel on Detection, Evaluation, and Treatment of
High Blood Cholesterol in Adults (Adults Treatment
Panel III) recommended secondary prevention with
lipid-lowering therapy based on different risk categories.
Those with coronary heart disease risk should be pro-
vided with therapy if LDL-cholesterol is ]3.4 mmol/L
(130 mg/dL); those with no or a single risk factor
are given drug therapy only if the LDL-cholesterol is
]4.9 mmol/L (190 mg/dL) (28). Although the proportion
of people taking lipid-lowering treatment has increased
overtime,around40%oftreatedmenandwomenhavenot
reached treatment goals. Providing cholesterol-lowering
agents aswell as lifestyle modification for individualswith
hypercholesterolemia is essential in preventing mortality
from ischemic heart disease. The total cholesterol level
is an independent risk factor for ischemic heart disease
at all blood pressure levels. A total cholesterol reduction
of 1 mmol/L reduces ischemic heart disease by half among
the population aged 4049 years, a third among those
aged 5069 years, and a sixth among those aged 7089
years (29).
Strengths and limitations
This repeated cross-sectional and panel dataset is unique
as it is integrated within the routine primary health care
system and the same questionnaires and protocols have
been used with only minor revisions over the last 20 years.
This provides high quality, comparable datasets across
time and allows trend measurements that are not feasible
in many settings. This dataset can provide reliable trends
in cholesterol levels. In contrast to the Northern Sweden
MONICA study, which is conducted on a random sample
of population in Norrbotten and Va ¨sterbotten counties
every five year, our data is collected continuously and
represents total population 40, 50 and 60 years old in
Va ¨sterbotten county who are invited to the health
examination.
While the protocol for cholesterol analysis changed in
the last few years, we have ensured the comparability of
the new and older data through a calibration study as
reported in the methods section. As the regression
coefficient is very close to 1 (0.932 for triglyceride and
0.939 for cholesterol), the intercept of the regression
formula (about 0.17 for triglyceride or cholesterol) shows
the difference between results from Reflotron and lab-
chemistry, which is very small. These confirm that results
from both measurements are very similar to each other.
The increase in cholesterol levels in the last three years
cannot be fully explained by this study. These needs
further exploration with inclusion of dietary intake
assessment and other lifestyle behaviour that is not
within the scope of this paper.
Conclusion
Despite the decreasing trends of population cholesterol
levels since 1990 among the adult Va ¨sterbotten popula-
tion, the reversal in trends since 2008 needs to be
monitored and seriously addressed. The consistent gaps
across population levels reflect the influence of socio-
demographic determinants in risk factor patterns. The
geographical differences in cholesterol levels need further
exploration by assessing the contribution of other risk
factors or socio-demographic determinants. Promoting
healthy lifestyles is important in reducing population
levels of cholesterol. In turn, this can prevent fatalities
from coronary heart disease and stroke.
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